首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Reduced-Intensity Conditioning (RIC) in Children with Nonmalignant Disorders (NMD) Undergoing Unrelated Donor Umbilical Cord Blood Transplantation (UCBT)
【24h】

Reduced-Intensity Conditioning (RIC) in Children with Nonmalignant Disorders (NMD) Undergoing Unrelated Donor Umbilical Cord Blood Transplantation (UCBT)

机译:非相关性供体脐带血移植(UCBT)的非恶性疾病(NMD)儿童的低强度调节(RIC)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

INTRODUCTION:Children, as opposed to adults, present with a variety of genetic nonmalignant disorders (NMD) that have the potential for significant morbidity and premature mortality. These disorders include, but are not limited to, hemoglobinopathies [1], bone marrow failure syndromes [2], inherited metabolic disorders [3], and primary immunodeficiency disorders [4]. Alloge-neic hematopoietic stem cell transplantation (HSCT) has been shown to be curative for several of these disorders-either by direct replacement of defective bone marrow precursors as in hemoglobinopathies, primary immunodeficiencies, and bone marrow failure syndromes, or indirectly by delivering normal enzymes to the affected tissues such as liver and brain, through the medium of donor cells [5]. However, unlike hema-tologic malignancies, patients with NMD generally do not receive chemotherapy or immunosuppressive therapy before HSCT and are appropriately regarded as chemotherapy naive, thereby implying increased resistance to engraftment compared to patients with hematologic malignancies.
机译:简介:与成年人相比,儿童表现出多种遗传性非恶性疾病(NMD),可能会导致高发病率和过早死亡。这些疾病包括但不限于血红蛋白病[1],骨髓衰竭综合征[2],遗传性代谢疾病[3]和原发性免疫缺陷疾病[4]。业已证明,同种异体造血干细胞移植(HSCT)可治愈其中的几种疾病-通过直接替代有缺陷的骨髓前体(如血红蛋白病,原发性免疫缺陷和骨髓衰竭综合征),或间接递送正常酶通过供体细胞[5]到达受影响的组织,如肝和脑。但是,与血液系统恶性肿瘤不同,NMD患者通常在HSCT之前不接受化学疗法或免疫抑制疗法,因此被认为是单纯化学疗法,因此与血液系统恶性肿瘤相比,对移植的抵抗力增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号